Literature DB >> 12222662

Studies on the antinociceptive, anti-inflammatory and anti pyretic effects of Isatis indigotica root.

Yu-Ling Ho1, Yuan-Shiun Chang.   

Abstract

The root of Isatis indigotica (Cruciferae), popularly known as Ban-Lan-Gen is used in traditional Chinese medicine for seasonal febrile diseases, pestilence, mumps, eruptive diseases, inflammatory diseases with redness of skin, sore throat, etc. In this study, we evaluated the antinociceptive, antiinflammatory and antipyretic effects of Isatis indigotica root methanolic extract. The results showed that Isatis indigotica root extract significantly and dose-dependently inhibited the writhing responses of mice and decreased the licking time in both the early and late phases of the formalin test. It also reduced the paw edema induced by carrageenan in rats. In addition, it potently attenuated pyrexia induced by lipopolysaccharide.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12222662     DOI: 10.1078/09447110260571661

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  20 in total

1.  A chromosome-scale genome assembly of Isatis indigotica, an important medicinal plant used in traditional Chinese medicine : An Isatis genome.

Authors:  Minghui Kang; Haolin Wu; Qiao Yang; Li Huang; Quanjun Hu; Tao Ma; Zaiyun Li; Jianquan Liu
Journal:  Hortic Res       Date:  2020-02-01       Impact factor: 6.793

2.  Functional Characterization of UDP-Glycosyltransferases Involved in Anti-viral Lignan Glycosides Biosynthesis in Isatis indigotica.

Authors:  Yuping Tan; Jian Yang; Yinyin Jiang; Jian Wang; Yahui Liu; Yujun Zhao; Baolong Jin; Xing Wang; Tong Chen; Liping Kang; Juan Guo; Guanghong Cui; Jinfu Tang; Luqi Huang
Journal:  Front Plant Sci       Date:  2022-06-14       Impact factor: 6.627

3.  High-throughput sequencing and De Novo assembly of the Isatis indigotica transcriptome.

Authors:  Xiaoqing Tang; Yunhua Xiao; Tingting Lv; Fangquan Wang; QianHao Zhu; Tianqing Zheng; Jie Yang
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

4.  Modes of Antiviral Action of Chemical Portions and Constituents from Woad Root Extract against Influenza Virus A FM1.

Authors:  Jia-Hang Su; Rui-Gang Diao; Shu-Guang Lv; Xiao-Dong Mou; Kefeng Li
Journal:  Evid Based Complement Alternat Med       Date:  2016-02-18       Impact factor: 2.629

5.  AP2/ERF Transcription Factor, Ii049, Positively Regulates Lignan Biosynthesis in Isatis indigotica through Activating Salicylic Acid Signaling and Lignan/Lignin Pathway Genes.

Authors:  Ruifang Ma; Ying Xiao; Zongyou Lv; Hexin Tan; Ruibing Chen; Qing Li; Junfeng Chen; Yun Wang; Jun Yin; Lei Zhang; Wansheng Chen
Journal:  Front Plant Sci       Date:  2017-08-04       Impact factor: 5.753

6.  Indole alkaloid sulfonic acids from an aqueous extract of Isatis indigotica roots and their antiviral activity.

Authors:  Lingjie Meng; Qinglan Guo; Yufeng Liu; Minghua Chen; Yuhuan Li; Jiandong Jiang; Jiangong Shi
Journal:  Acta Pharm Sin B       Date:  2017-04-29       Impact factor: 11.413

7.  Aromatic compounds from an aqueous extract of "ban lan gen" and their antiviral activities.

Authors:  Yufeng Liu; Minghua Chen; Qinglan Guo; Yuhuan Li; Jiandong Jiang; Jiangong Shi
Journal:  Acta Pharm Sin B       Date:  2016-11-08       Impact factor: 11.413

8.  LC-APCI-MS method for detection and analysis of tryptanthrin, indigo, and indirubin in daqingye and banlangen.

Authors:  Bing-Chung Liau; Ting-Ting Jong; Maw-Rong Lee; Shih-Shiung Chen
Journal:  J Pharm Biomed Anal       Date:  2006-08-01       Impact factor: 3.935

9.  Three pairs of alkaloid enantiomers from the root of Isatis indigotica.

Authors:  Yufeng Liu; Xiaoliang Wang; Minghua Chen; Sheng Lin; Li Li; Jiangong Shi
Journal:  Acta Pharm Sin B       Date:  2016-02-11       Impact factor: 11.413

10.  8,4'-Oxyneolignane glucosides from an aqueous extract of "ban lan gen" (Isatis indigotica root) and their absolute configurations.

Authors:  Lingjie Meng; Qinglan Guo; Yufeng Liu; Jiangong Shi
Journal:  Acta Pharm Sin B       Date:  2017-10-18       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.